KR960004341A - 치환1-(7-클로로 퀴놀린-4-일) 피라졸-3- 카르복스아미드 n-옥시드 유도체, 그의 제조 방법 및 그를 함유하는 약학적 조성물 - Google Patents

치환1-(7-클로로 퀴놀린-4-일) 피라졸-3- 카르복스아미드 n-옥시드 유도체, 그의 제조 방법 및 그를 함유하는 약학적 조성물 Download PDF

Info

Publication number
KR960004341A
KR960004341A KR1019950020074A KR19950020074A KR960004341A KR 960004341 A KR960004341 A KR 960004341A KR 1019950020074 A KR1019950020074 A KR 1019950020074A KR 19950020074 A KR19950020074 A KR 19950020074A KR 960004341 A KR960004341 A KR 960004341A
Authority
KR
South Korea
Prior art keywords
formula
compound
hydrogen
cycloalkylmethyl
methoxyethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1019950020074A
Other languages
English (en)
Korean (ko)
Inventor
르부아쥬그랭 로베
귈리 다니엘
쟝쟝 프랑시스
프라딘느 앙뜨완느
Original Assignee
로날 샤삐라
사노피
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로날 샤삐라, 사노피 filed Critical 로날 샤삐라
Publication of KR960004341A publication Critical patent/KR960004341A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019950020074A 1994-07-08 1995-07-08 치환1-(7-클로로 퀴놀린-4-일) 피라졸-3- 카르복스아미드 n-옥시드 유도체, 그의 제조 방법 및 그를 함유하는 약학적 조성물 Abandoned KR960004341A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR94-08459 1994-07-08
FR9408459A FR2722193B1 (fr) 1994-07-08 1994-07-08 Derives n-oxydes de 1-(7-chloro-4-quinoleinyl)pyrazole-3-carboxamides substitues, procede pour leur preparation et les compositions pharmaceitiques les contenant

Publications (1)

Publication Number Publication Date
KR960004341A true KR960004341A (ko) 1996-02-23

Family

ID=9465167

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950020074A Abandoned KR960004341A (ko) 1994-07-08 1995-07-08 치환1-(7-클로로 퀴놀린-4-일) 피라졸-3- 카르복스아미드 n-옥시드 유도체, 그의 제조 방법 및 그를 함유하는 약학적 조성물

Country Status (17)

Country Link
US (1) US5561234A (enExample)
EP (1) EP0695747A1 (enExample)
JP (1) JPH0841051A (enExample)
KR (1) KR960004341A (enExample)
CN (1) CN1042533C (enExample)
AU (1) AU695588B2 (enExample)
CA (1) CA2153432A1 (enExample)
FI (1) FI953360A7 (enExample)
FR (1) FR2722193B1 (enExample)
HU (1) HUT73175A (enExample)
IL (1) IL114500A (enExample)
NO (1) NO952715L (enExample)
NZ (1) NZ272525A (enExample)
PL (1) PL309546A1 (enExample)
RU (1) RU2145323C1 (enExample)
TW (1) TW318847B (enExample)
ZA (1) ZA955673B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033531A1 (en) * 1997-02-03 1998-08-06 Mallinckrodt Medical, Inc. Method for the detection and localization of malignant human tumours
AR038967A1 (es) * 2002-03-18 2005-02-02 Solvay Pharm Bv Derivados de 2,3 - diaril - pirazolidinas como inhibidores de enzimas que degradan la neurotensina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU541846A1 (ru) * 1975-10-28 1977-01-05 Донецкое Отделение Физико-Органической Химии Института Физической Химии Им. Л.В.Писаржевского Ан Украинской Сср Способ получени 2-гетерилзамещенных бензимидазола
JPS5283852A (en) * 1976-01-01 1977-07-13 Christiaens Sa A Pyridine derivatives
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters
JPH02268162A (ja) * 1989-04-10 1990-11-01 Fujisawa Pharmaceut Co Ltd ジフェニルピリジン誘導体
FR2665898B1 (fr) * 1990-08-20 1994-03-11 Sanofi Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
FI953360L (fi) 1996-01-09
EP0695747A1 (fr) 1996-02-07
ZA955673B (en) 1996-02-20
CA2153432A1 (en) 1996-01-09
NZ272525A (en) 1997-02-24
NO952715D0 (no) 1995-07-07
PL309546A1 (en) 1996-01-22
FI953360A7 (fi) 1996-01-09
HU9502081D0 (en) 1995-09-28
IL114500A0 (en) 1995-11-27
AU695588B2 (en) 1998-08-20
FR2722193A1 (fr) 1996-01-12
FR2722193B1 (fr) 1996-10-04
JPH0841051A (ja) 1996-02-13
CN1042533C (zh) 1999-03-17
NO952715L (no) 1996-01-09
HUT73175A (en) 1996-06-28
AU2486795A (en) 1996-01-18
US5561234A (en) 1996-10-01
TW318847B (enExample) 1997-11-01
IL114500A (en) 1999-11-30
CN1120042A (zh) 1996-04-10
FI953360A0 (fi) 1995-07-07
RU2145323C1 (ru) 2000-02-10

Similar Documents

Publication Publication Date Title
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
BG106439A (en) Pharmaceutical composition of improved solubility and oral absorptivity, containing benzamide derivative
DK66789D0 (da) Bicycloheptencarboxylsyrederivater
ATE126216T1 (de) Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
ATE109149T1 (de) 3-pyrrolidinylthio-1-azabicyclo(3.2.0>-hept-2-e - 2-carbonsäureverbindungen.
KR970706021A (ko) N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형제제(MEDICINAL ADJUVANTS CONSISTIONG OF AN N-SUBSTITUED-o-TOLUIDING DERIVANTIVE, AND PERCUTANEOUSLY ABSORBALE PREPARATIONS COMPRISING THE ADJUVANTS)
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
KR940005274A (ko) 쇼그렌(Sjoegren)증후군 치료제
DK96786D0 (da) Aminosyrederivater
KR970707108A (ko) 항염증제로 유용한, 복소환부를 갖는 디-t-부틸페놀 화합물(DI-TERT-BUTYLPHENOL COMPOUNDS WITH HETEROCYCLIC MOIETY, USEFUL AS ANTI-INFLAMMATORY AGENTS)
NO158017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
KR900014406A (ko) 세펨 화합물 및 이의 제조방법
IL92799A0 (en) Benzimidazole derivatives with gastric acid inhibition and process for its preparation
AU558261B2 (en) Dialkylaminoalkyoxybenzylalcohol derivatives
KR960004341A (ko) 치환1-(7-클로로 퀴놀린-4-일) 피라졸-3- 카르복스아미드 n-옥시드 유도체, 그의 제조 방법 및 그를 함유하는 약학적 조성물
CA2256391A1 (en) Anticoagulant peptidyl-arginine aldehyde derivatives
KR930023338A (ko) 데포우 제제
EP0228314A3 (en) Use of ethanol/amine derivatives in treating or preventing hyperlipemia
KR890003755A (ko) 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
KR980002033A (ko) 트리아졸 유도체 또는 그 염
IE39679B1 (en) Methods and compositions for killing parasites of warm blooded animals
KR910009718A (ko) 프라디미신 유도체
KR960702445A (ko) 1-(2-벤조이미다졸일)-1, 5- 디아자시클로옥탄 유도체(1-(2-benzimidazo-lyl)-1,5-diazacyclooctane compounds)
ATE21908T1 (de) Derivate von 1,4-diaminocyclitol, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19950708

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19970827

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19950708

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19990617

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19990929

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee